Recently, overseas giantsThe publication of the first quarter financial report this year can be described as having both positive and negative aspects. High value-added medical device companies like Boston Scientific and Intuitive, which are known for their technological strengths, have been less affected by tariffs. However, medical device companies that mainly focus on low-value consumables, with lower product added value and high cost requirements, have been significantly impacted.For medical giants like Cardinal Health, tariffs have a significant impact. The company recently stated that the newly implemented import tariffs...Could lead to a loss of up to $300 million for the company. To mitigate the impact, it will address the issue through measures such as layoffs. It believes that tariff costs will primarily affect its Global Medical Products and Distribution (GMPD) business segment."The company is actively communicating with the Trump administration, 'trying to mitigate the impact on patient care.' In the GMPD sector, we have implemented a series of forward-looking measures to minimize the burden on customers. These include expanding the production capacity of key categories such as U.S.-made syringes and incontinence care; optimizing the supplier network layout to avoid high-risk areas; establishing diversified supply channels (strategic inventory reserves in some cases); utilizing artificial intelligence to optimize tariff planning and compliance management; and continuously reducing internal cost structures. Only after fully implementing the above mitigation measures will we consider price adjustments. To date, these actions have successfully offset hundreds of millions of dollars in risk exposure."---Jason Hollar Cardinal Health CEOExcept forBesides Cardinal Health, giants such as Johnson & Johnson and Stryker also expressed concerns about the tariffs and have thus increased the tariff costs of their related products.
Johnson & Johnson: Expected to Cut Financial Forecast By$400 million(approximately RMB 2.93 billion), this impact is mainly due to the tariff pressure faced by U.S. exports of medical devices to China;
Stryker:Due to the new tariff policy of the Trump administration, the full-year adjusted EPS forecast was lowered from $13.45-13.70 to $13.20-13.45, with an estimated tariff impact reaching$200 million；（But for the tariff raid, the profit guidance should have been raised）Boco:The Tariff Impact for the Whole Year Will Be2Billion US dollars, but also optimistically stated that the impact of this part of the tariff will be offset by sales growth and the use of some financial measures;GE: Due to the tariffs imposed by the Trump administration, its revenue in 2025 will be affected by approximately$500 millionThe blow;BD: Downward adjustment of annual profit forecast, with expected revenue between 21.8 billion USD and 21.9 billion USD, tariff impact on U.S. earnings reached$0.25。As more and more giants release their first-quarter earnings reports this year, the impact of tariffs will become increasingly clear. Some companies have begun to apply.Tariff exemptions; some are increasing investment in the U.S.; some are even starting layoffs; others, due to performance growth (high product added value), are not significantly affected and only need to make some adjustments.Financial means can offset the impact of tariffs. It can be said that each company is affected differently by tariffs due to different business content. Some respond calmly, while others are more aggressive. Ultimately, hard technology is needed, as hard technology represents the solid strength to deal with any突发事件.
